Why You Should Attend IN3 Medical Device 360 Summit This Fall

IN3 brings together buy side strategics, VCs, and medtech innovators to build the necessary connections to expand portfolios, secure funding, and drive medical device progress. This event not only provides you with insights from experienced strategics and investors, it also provides you with a state-of-the art partnering tool to maximizes your networking capabilities.

Top Reasons to Attend IN3:

Know What Investors Look For. Crafting the right narrative and showcasing the best value metrics are essential to selling your technology. Discover exactly what criteria Strategics and VCs use to evaluate potential acquisitions. Download the agenda: http://bit.ly/1OCI0nd

Pitch to Put Your Technology on the Map. Competition is fierce in the medtech sector. Do what it takes to rise above your rivals -- pitch your technology to a global audience of top-tier investors. Secure Your Spot before Your Rivals Take it. Apply Now: http://bit.ly/1izpUbE

Find Your Next Partner. Introducing partneringONE®, the perfect platform for meeting exactly the right person at exactly the right time. Leverage partneringONE® to pre-arrange one-on-one meetings with the high-level decision makers you’ve been searching for. Move beyond chance encounters and conduct more quality meetings in two days than most companies do throughout the entire year.  Explore how it works: http://bit.ly/1KcxBPp

Also, here’s the event’s keynote lineup:

• Chris King, VP, Business Development and Strategic Partnering, Medtronic
• Bill Roskopf, VP, Business Development and Strategic Planning, Stryker
• Sherrie Perkins, VP, Business Development, Sorin Group
• Evelyn Douglas, VP, Corporate Strategy & Development, BD
• Jeff Karan, Managing Partner, Mavericks Capital
• Gil Kliman, Managing Director, InterWest Partners
• Ted Driscoll, Partner, Digital Healthcare Lead, Claremont Creek Ventures
• John Ryan, Partner, ONSET Ventures
• David Allison, Investment Professional, Versant Ventures
• Andrew Baldwin, Principal, Western Technology Investment
• Arthur Pappas, Managing Partner, Pappas Ventures
• Ittai Harel, General Partner, Pitango Venture Capital
• Gregory Grunberg, Managing Director, Longitude Capital
• Zack Scott, Managing Partner, Leerink Revelation Partners
• Bill Starling, Managing Director, Synergy Life Science Partners
• Jeffery T. Barnes, Managing Director, BioVentures Investors
• Greg Grunberg, Managing Director, Longitude Capital

As a valued reader of our blog, you get an exclusive $100 off the current rate when you use code IN315BL to register: http://bit.ly/1OCI0nd

We hope to see you in San Francisco this Fall!

Cheers,

The IN3 Team

@FutureofBioPharma

#IN3SF

Share this article with your social network, just click below to share now!

Share |